Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer.
Publication/Presentation Date
3-1-2024
Abstract
Clinical genomic testing of patient germline, tumor tissue, or plasma cell-free DNA can enable a personalized approach to cancer management and treatment. In prostate cancer (PCa), broad genotyping tests are now widely used to identify germline and/or somatic alterations in
Volume
8
First Page
2300654
Last Page
2300654
ISSN
2473-4284
Published In/Presented At
Vandekerkhove, G., Giri, V. N., Halabi, S., McNair, C., Hamade, K., Bitting, R. L., & Wyatt, A. W. (2024). Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer. JCO precision oncology, 8, e2300654. https://doi.org/10.1200/PO.23.00654
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
38547422
Department(s)
Administration and Leadership
Document Type
Article